This strategy features in the framework of Agenda 21 as formulated at UNCED (Rio de Janeiro, 1992), now coordinated by the United Nations Commission on Sustainable Development and implemented through national and local authorities.
Agenda 21 recommends: establishing and enforcing screening, systematic sampling and evaluation procedures for drugs and medical technologies, with a view to barring the use of those that are unsafe for the purposes of experimentation; ensuring that drugs and technologies relating to reproductive health are safe and effective and take account of ethical considerations.